Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Human Reproduction

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HUMREP/16.12.2552PMID 11726573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome.

  2001cited by this paper
• Allelic variants of the follistatin gene in polycystic ovary syndrome.

  2000cited by this paper
• Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome.

  2000cited by this paper
• Activin effects on neoplastic proliferation of human pituitary tumors.

  2000cited by this paper
• Release of activin and follistatin during cardiovascular procedures is largely due to heparin administration.

  2000cited by this paper
• Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women.

  2000cited by this paper
• Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin.

  2000cited by this paper
• Activin A stimulates insulin secretion in cultured human pancreatic islets

  2000cited by this paper
• Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders.

  2000cited by this paper
• Changes in serum inhibin, activin and follistatin concentrations during puberty in girls.

  2000cited by this paper
• Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

  1999influential reference
• Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome.

  1998cited by this paper
• Phenotype and genotype in polycystic ovary syndrome.

  1998influential reference
• Activin/follistatin and atherosclerosis--a review.

  1998cited by this paper
• Involvement of growth factors in the pathophysiology of polycystic ovary syndrome.

  1998cited by this paper
• Serum follistatin concentrations are increased in patients with septicaemia

  1998cited by this paper
• A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state.

  1998cited by this paper
• Overexpression of mouse follistatin causes reproductive defects in transgenic mice.

  1998cited by this paper
• Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin.

  1998cited by this paper
• Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation.

  1997cited by this paper
• Activins, Inhibins, and Follistatins: Further Thoughts on a Growing Family of Regulators 1

  1997cited by this paper
• Serum immunoreactive activin A levels in normal subjects and patients with various diseases.

  1996cited by this paper
• Circulating inhibins and activin A during GnRH‐analogue down‐regulation and ovarian hyperstimulation with recombinant FSH for in‐vitro fertilization‐embryo transfer

  1996cited by this paper
• Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy.

  1996influential reference
• Serum immunoreactive activin A levels in normal subjects and patients with various diseases

  1996cited by this paper
• Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid.

  1996cited by this paper
• Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines.

  1996cited by this paper
• Circulating levels of follistatin from puberty to menopause.

  1996influential reference
• Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin.

  1995influential reference
• Follistatin concentrations in follicular fluid of normal and polycystic ovaries.

  1995cited by this paper
• Polycystic ovary syndrome/hyperandrogenic chronic anovulation.

  1995cited by this paper
• Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.

  1994cited by this paper
• Human plasma free activin and inhibin levels during the menstrual cycle.

  1993cited by this paper
• The Inhibin/Activin Family of Hormones and Growth Factors

  1990cited by this paper
• Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad.

  1987cited by this paper
• Multifollicular ovaries: Clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

  1987cited by this paper
• The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin.

  1987cited by this paper
• Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.

  1987cited by this paper
• Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.

  1985cited by this paper

• TGF-β Signaling in the Pathophysiology of the Ovary: A Double-Edged Regulator

  2026cites this paper
• Higher serum follistatin levels are associated with increased vascular calcification in haemodialysis patients.

  2026cites this paper
• TGF-β signaling in the ovary: Emerging roles in development and disease.

  2025cites this paper
• Role of Activin A, Fibrillin-3 Hormone and Betacellulin Growth Factor on Implantation Rate in PCOS and Non-PCOS Women Undergo ART

  2025cites this paper
• Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets.

  2025cites this paper
• Follistatin levels and endocrine disorders: A two-sample Mendelian randomization study

  2025cites this paper
• Impact of a hypocaloric dietary intervention on antral follicle dynamics in eumenorrheic women with obesity.

  2024cites this paper
• Follistatin-respiratory connection predicting all-cause mortality among community-dwelling middle-to-old age individuals: Results from the I-Lan Longitudinal Study

  2024cites this paper
• The Effect of Metformin and Carbohydrate-Controlled Diet on DNA Methylation and Gene Expression in the Endometrium of Women with Polycystic Ovary Syndrome

  2023cites this paper
• The lymphatic endothelium-derived follistatin: activin A axis regulates neutrophil motility in response to Pseudomonas aeruginosa.

  2023cites this paper
• Follistatin and follistatin-like 3 in metabolic disorders.

  2023cites this paper
• Metabolic characteristics of obese patients with polycystic ovarian syndrome: a meta-analysis

  2023cites this paper
• The Upregulation of HAS2-AS1 Relates to the Granulosa Cell Dysfunction by Repressing TGF-β Signaling and Upregulating HAS2

  2022cites this paper
• Regulatory Role and Potential Importance of GDF-8 in Ovarian Reproductive Activity

  2022cites this paper
• Endometriosis and polycystic ovary syndrome are diametric disorders

  2021cites this paper
• Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis

  2021cites this paper
• Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome

  2020cites this paper
• Activin and inhibin signaling: From regulation of physiology to involvement in the pathology of the female reproductive system.

  2020cites this paper
• Altered m6A modification is involved in up‐regulated expression of FOXO3 in luteinized granulosa cells of non‐obese polycystic ovary syndrome patients

  2020cites this paper
• MALAT1 is involved in the pathophysiological process of PCOS by modulating TGFβ signaling in granulosa cells.

  2020cites this paper
• Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS.

  2020cites this paper
• Dysregulated miR-142, -33b, and -423 in granulosa cells target TGFBR1 and SMAD7: a possible role in polycystic ovary syndrome.

  2019cites this paper
• Effect of Follicular Activin a and Granulocyte Macrophage-Colony Stimulating Factor on the Prediction of Pregnancy Rate Following Intracytoplasmic Sperm Injection in Women with PCOS

  2019cites this paper
• Serum follistatin and its role in intracytoplasmic sperm injection outcomes

  2019cites this paper
• ALK4-SMAD2/3-SMAD4 signaling mediates the activin A-induced suppression of PTX3 in human granulosa-lutein cells.

  2019cites this paper
• DNA Methylation in the Pathogenesis of Polycystic Ovary Syndrome.

  2019cites this paper
• Cell-Cell Interactions in Ovarian Follicles: Role of TGF-β Superfamily Members

  2019cites this paper
• Physiological roles of activins in the human ovary

  2018cites this paper
• Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome

  2018cites this paper
• Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.

  2018cites this paper
• Tight interplay in early pregnancy between follistatin and anti-mullerian hormone in women with polycystic ovarian syndrome (PCOS)

  2018influential citation
• Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish

  2017cites this paper
• Cryptotanshinone reverses reproductive disturbances in rats with dehydroepiandrosterone-induced polycystic ovary syndrome.

  2017cites this paper
• Alteration in follistatin gene expression detected in prenatally androgenized rats

  2017cites this paper
• Qualité ovocytaire et embryonnaire chez les femmes avec syndrome des ovaires polykystiques : état de l’art

  2017cites this paper
• The level of follistatin and activin in follicular fluid of long protocol in in vitro fertilization

  2017cites this paper
• Time-lapse imaging provides further evidence that planar arrangement of blastomeres is highly abnormal

  2017cites this paper
• [Quality of oocytes and embryos from women with polycystic ovaries syndrome: State of the art].

  2017cites this paper
• ROLE OF HEPARIN BINDING EPIDERMAL GROWTH FACTOR IN THE SERUM AND FOLLICULAR FLUID IN PREDICTION OF PREGNANCY OUTCOME OF INFERTILE WOMEN WITH AND WITHOUT PCOS.

  2017cites this paper
• Serum AMH level predicts oocytes quality better than follicular fluid AMH level

  2016cites this paper
• Circulating follistatin in relation to energy metabolism.

  2016cites this paper
• Activins in reproductive biology and beyond.

  2016cites this paper
• Increased follistatin associated with decreased gait speed among old adults

  2016cites this paper
• A SYSTEMIC REVIEW ON DIFFERENTIAL REGULATION OF GENES IN POLYCYSTIC OVARIAN SYNDROME DISEASE

  2015cites this paper
• Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA.

  2015cites this paper
• Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.

  2015cites this paper
• Study of the association of the T869C polymorphism of the transforming growth factor-β1 gene with polycystic ovary syndrome.

  2015cites this paper
• The Role of TGF-β in Polycystic Ovary Syndrome

  2014cites this paper
• The role of AMH in anovulation associated with PCOS: a hypothesis.

  2014cites this paper
• Modulation of Follistatin and Myostatin Propeptide by Anabolic Steroids and Gender

  2013cites this paper
• Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.

  2013cites this paper
• Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low‐grade inflammation

  2013cites this paper
• Ontogeny of the ovary in polycystic ovary syndrome.

  2013cites this paper
• in Polycystic Ovary Syndrome β The Role of TGF -

  2013cites this paper
• Doves, Diplomats, and Diabetes

  2013cites this paper
• Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.

  2013cites this paper
• Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.

  2013cites this paper
• Bone morphogenetic proteins and the polycystic ovary syndrome

  2013cites this paper
• Gene expression patterns in human adipose tissue in relation to fat mass and adipose depot

  2012cites this paper
• Adipose Tissue's Potential Role as a Reproductive or Lactation Endocrine Gland

  2012cites this paper
• Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys

  2011cites this paper
• Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells

  2011cites this paper
• Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes.

  2011cites this paper
• Erratum zu Charakterisierung der molekularen Mechanismen des Adipokins Adiponectin bei der Nicht-alkoholischen Steatohepatitis (NASH)

  2011cites this paper
• Correlation analysis of inhibin B, follistatin and activin A in patients with polycystic ovary syndrome

  2010cites this paper
• Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.

  2010cites this paper
• Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence

  2010cites this paper
• Follistatin concentrations in women from Kerala with polycystic ovary syndrome

  2010cites this paper
• Aberrantly increased mRNA expression of betaglycan, an inhibin co‐receptor in the ovarian tissues in women with polycystic ovary syndrome

  2010cites this paper
• Effects and mechanisms of growth differentiation factor 9 on activin A-regulated inhibin B and progesterone production in human granulosa cells

  2010cites this paper
• A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome.

  2010cites this paper
• Implications of Polycystic Ovary Syndrome (PCOS) on Oocyte Development

  2009cites this paper
• Normal ovaries, inflammatory and non-neoplastic conditions

  2009cites this paper
• JOURNAL OF NEUROCHEMISTRY | 2009 | 110 | 1014–1027 doi: 10.1111/j.1471-4159.2009.06192.x

  2009cites this paper
• The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.

  2009cites this paper
• Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein‐dependent mechanism involving hypothalamic‐pituitary‐gonadal axis receptors

  2009cites this paper
• Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes.

  2009cites this paper
• Role of follistatin in promoting adipogenesis in women.

  2009cites this paper
• Implications of Polycystic Ovary Syndrome on Oocyte Development

  2008cites this paper
• Implications of polycystic ovary syndrome on oocyte development.

  2008cites this paper
• Ovarian reserve testing in premenopausal recipients of chemotherapy for breast cancer.

  2008cites this paper
• Accounting for the Follicle Population in the Polycystic Ovary

  2008cites this paper
• Polycystic Ovary Syndrome and Oocyte Developmental Competence

  2008cites this paper
• High serum follistatin levels in women with ovarian endometriosis.

  2007cites this paper
• Polycystic ovary syndrome and its developmental origins

  2007cites this paper
• Activin is critical for the development of pain hypersensitivity after inflammation.

  2007cites this paper
• Polymorphism of the follistatin gene in polycystic ovary syndrome.

  2007cites this paper
• Growth factors and folliculogenesis in polycystic ovary patients

  2007cites this paper
• Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.

  2007cites this paper
• Ovarian Steroidogenic Abnormalities in the Polycystic Ovary Syndrome

  2006cites this paper
• Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.

  2006cites this paper
• The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain.

  2005cites this paper
• Candidate‐based proteomics in the search for biomarkers of cardiovascular disease

  2005influential citation
• PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?

  2005cites this paper
• Alzheimer’s disease: the impact of age-related changes in reproductive hormones

  2004cites this paper
• Activin and follistatin in female reproduction.

  2004cites this paper
• [Insulin resistance inpolycystic ovary syndrome].

  2004cites this paper
• Living and Dying for Sex

  2004cites this paper
• The Role of the Ovary in the Genesis of Hyperandrogenism

  2003cites this paper
• Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine.

  2003cites this paper